Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:35:41 EDT Fri 04 Oct 2024
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDNA - MEDICENNA THERAPEUTICS CORP. J - http://www.medicenna.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDNA - T  4.72.18·2.221.02.20+0.157.3243.15145472.08  2.28  2.052.98  0.21516:00:0009:0715 min RT 2¢
TSX - T4.72.18·2.221.02.20+0.157.3130.92802542.08  2.28  2.082.98  0.21516:00:0015 min
NEO ATS - U 2.18+0.136.310.121142.09  2.23  2.0915:57:5915 min
Alpha - A 2.18+0.136.327.559142.05  2.23  2.0515:59:3015 min
Omega - O 2.18+0.136.30.4132.18  2.20  2.1815:55:5015 min
Pure - P 2.050.305    Sep 1615 min
Chi-X - X 2.18+0.136.38.618442.09  2.26  2.0915:59:5915 min
CX2 - H 2.19+0.146.859.01241282.09  2.28  2.0515:59:3015 min
CXD - D 2.215+0.1658.02.75292.265  2.265  2.1114:21:0315 min
TriAct - M 2.053.6656    Sep 11-2015 min

Recent Trades - Last 10 of 547
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00T2.200.15180 National Bank7 TD SecQ
16:00:00T2.200.151001 Anonymous7 TD SecKQ
15:59:59T2.180.1320085 Scotia79 CIBCK
15:59:59X2.180.131001 Anonymous1 AnonymousK
15:59:51T2.200.1510079 CIBC79 CIBCK
15:59:30A2.180.131,50039 Merrill Lynch1 AnonymousK
15:59:30H2.190.148001 Anonymous39 Merrill LynchK
15:59:07H2.190.141001 Anonymous1 AnonymousK
15:58:44T2.200.1510079 CIBC80 National BankK
15:58:44T2.200.169080 National Bank85 Scotia

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-10-04 09:07C:MDNA2.05News ReleaseMedicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
2024-09-26 18:27C:MDNA1.88News ReleaseMedicenna Therapeutics holders approve AGM resolutions
2024-09-09 16:40C:MDNA2.22News ReleaseMedicenna presents preclinical results in France
2024-08-27 07:00C:MDNA2.16News ReleaseMedicenna Announces Upcoming Presentations at The Promise of Interleukin-2 Therapy Conference
2024-08-15 15:46C:MDNA2.13News ReleaseMedicenna Therapeutics appoints Lalji to board
2024-08-01 07:00C:MDNA2.13News ReleaseMedicenna Reports First Quarter Fiscal 2025 Financial Results and Announces First Complete Responder with MDNA11 Monotherapy
2024-07-31 21:27C:MDNA2.13SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-07-31 21:27C:MDNA2.13SEDAR Interim MD & ASEDAR Interim MD & A
2024-07-26 16:52C:MDNA2.22MiscellaneousMedicenna Therapeutics has change in transfer agent
2024-06-27 18:36C:MDNA1.98News ReleaseMedicenna's March 31 cash position at $17-million
2024-06-27 00:52C:MDNA2.07SEDAR Annual Information FormSEDAR Annual Information Form
2024-06-27 00:39C:MDNA2.07SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-06-27 00:39C:MDNA2.07SEDAR MD & ASEDAR MD & A
2024-06-26 12:40C:MDNA2.07News ReleaseMedicenna receives EMA approval for Ability-1 trial
2024-06-03 12:30C:MDNA2.57News ReleaseMedicenna presents phase 2b bizaxofusp results at ASCO
2024-05-13 11:55C:MDNA2.47News ReleaseMedicenna denies breaking ASCO prior-publication policy
2024-04-30 14:50C:MDNA2.31News ReleaseMedicenna closes $20M investment from RA Capital
2024-04-26 09:09C:MDNA2.49News ReleaseMedicenna arranges $20M private placement
2024-04-26 08:09C:MDNA1.95Resume TradingMedicenna Therapeutics resuming at the open
2024-04-26 08:02C:MDNA1.95Halt TradingMedicenna Therapeutics halted at the open